InvestorPlace – Stock Market News, Stock Advice & Trading Tips The first time that I wrote about Inovio Pharmaceuticals (NASDAQ:INO) in Jan. 2020, it traded at just $4.86 per share .INO stock subsequently soared to $27 in July. Source: Ascannio / Shutterstock.com Afterwards, I said that INO stock could rise to […]
Pharmaceuticals
Jane Street Group LLC lowered its position in Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) by 20.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,505 shares of the company’s stock after selling 2,516 shares during the […]
Marinus Pharmaceuticals (NASDAQ:MRNS) had its target price raised by HC Wainwright from $9.00 to $35.00 in a report released on Monday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently commented on MRNS. SVB Leerink lifted their […]
TRACON Pharmaceuticals Inc (NASDAQ:TCON) shares traded up 11% during trading on Monday after an insider bought additional shares in the company. The company traded as high as $5.64 and last traded at $5.34. 1,149,574 shares traded hands during mid-day trading, an increase of 36% from the average session volume of […]
Aerie Pharmaceuticals (NASDAQ:AERI)‘s stock had its “hold” rating reaffirmed by research analysts at Raymond James in a report issued on Monday, AnalystRatings.com reports. Several other equities analysts have also recently commented on AERI. Needham & Company LLC initiated coverage on shares of Aerie Pharmaceuticals in a research report on Friday, […]
Handelsbanken Fonder AB purchased a new stake in shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 3,858 shares of the biotechnology company’s stock, valued at approximately $432,000. Other institutional investors […]
Bank of Montreal Can increased its position in shares of Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) by 249.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 978 shares of the biopharmaceutical company’s stock after buying an additional 698 shares during the […]
Brokerages expect Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) to report ($0.22) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for Aurinia Pharmaceuticals’ earnings. The lowest EPS estimate is ($0.25) and the highest is ($0.20). Aurinia Pharmaceuticals posted earnings of ($0.21) per share […]
JPMorgan Chase & Co. began coverage on shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) in a research note released on Tuesday morning, The Fly reports. The brokerage issued an overweight rating on the biotechnology company’s stock. A number of other equities research analysts have also recently issued reports on BCRX. Royal Bank […]
Inovio Pharmaceuticals Inc (NASDAQ:INO)’s stock price gapped down prior to trading on Monday after Roth Capital lowered their price target on the stock from $11.00 to $8.00. The stock had previously closed at $16.94, but opened at $13.50. Inovio Pharmaceuticals shares last traded at $11.12, with a volume of 268,370 […]
Aridis Pharmaceuticals Inc (NASDAQ:ARDS)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $7.34, but opened at $6.99. Aridis Pharmaceuticals shares last traded at $7.19, with a volume of 2,800 shares trading hands. ARDS has been the topic of several analyst reports. Zacks […]
Shares of Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) have been assigned a consensus recommendation of “Buy” from the eleven research firms that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average […]
Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) was the recipient of a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 27,000 shares, a decrease of 18.7% from the August 31st total of 33,200 shares. Based on an average daily volume of 201,500 […]
Brokerages expect Enanta Pharmaceuticals Inc (NASDAQ:ENTA) to report $40.12 million in sales for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for Enanta Pharmaceuticals’ earnings. The highest sales estimate is $87.82 million and the lowest is $21.32 million. Enanta Pharmaceuticals reported sales of $51.31 million […]
News stories about Inovio Pharmaceuticals (NASDAQ:INO) have been trending very negative this week, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by monitoring more than 6,000 blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores […]
Grafiche Pizzi installs new Speedmaster XL 106-2-P with CutStar –the 400th roll sheeter installation worldwide CutStar is synonymous with lower costs, less paper waste, greater flexibility, and extremely short makeready times Company has installed more than fifteen million euros worth of Heidelberg products in the last four years […]
Momenta Pharmaceuticals (NASDAQ:MNTA) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, BidAskClub reports. Several other equities research analysts have also commented on MNTA. Cowen upgraded shares of Momenta Pharmaceuticals from a “market perform” rating to […]
Analysts expect that Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) will announce $38.62 million in sales for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for Arrowhead Pharmaceuticals’ earnings, with estimates ranging from $10.00 million to $104.80 million. Arrowhead Pharmaceuticals posted sales of $43.29 million during the same quarter […]
Pfizer has announced an equity investment of $200m to purchase a 9.90% stake in biopharmaceutical company CStone Pharmaceuticals. Under the deal, CStone and Pfizer will involve in the development and commercialisation of CStone’s sugemalimab, an investigational anti-PD-L1 monoclonal antibody, in mainland China. They will also co-develop selected late-stage oncology assets […]
Milestone Pharmaceuticals (NASDAQ:MIST) was upgraded by ValuEngine from a “buy” rating to a “strong-buy” rating in a report issued on Thursday, ValuEngine reports. MIST has been the subject of several other reports. Oppenheimer raised Milestone Pharmaceuticals from a “market perform” rating to an “outperform” rating and set a $18.00 price […]
Ligand Pharmaceuticals (NASDAQ:LGND) had its target price raised by equities researchers at Roth Capital from $190.00 to $195.00 in a note issued to investors on Tuesday, The Fly reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Roth Capital’s price target suggests a potential upside of […]
Berenberg Bank started coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) in a report released on Wednesday morning, The Fly reports. The brokerage issued a hold rating on the biopharmaceutical company’s stock. ALNY has been the topic of a number of other research reports. BMO Capital Markets upped their target price […]
BHR specializes in innovative diagnostic solutions for point of care Collaboration focusses on SphingoTec’s proprietary assays for bio-ADM(R), penKid(R) and DPP3 Investigator-initiated study in COVID-19 at Guy’s & St Thomas’ Hospital and King’s College Hospital NHS Trust WARWIICKSHIRE, UK and HENNIGDORF, GERMANY / ACCESSWIRE / September 29, 2020 / BHR […]
EDISON, NJ / ACCESSWIRE / September 29, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”), today announced that Dr. Robert Foster, Hepion’s CEO, will present virtually at the H.C. Wainwright 4th […]
MOSCOW, Sept. 29, 2020 /PRNewswire/ — The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and one of the leading pharmaceutical distributors in Nepal, Trinity Pharmaceuticals, have agreed to supply to the country 25 million doses of the Sputnik V vaccine based on a well-studied human adenoviral vectors platform. […]